Skip to main content

9 Meters Biopharma, Inc.

NMTRDelisted Sep 8, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001551986

9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding 9 Meters Biopharma, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of NMTR: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders74242−30
SharesConverted for a 1-for-20 split2.42M1.89K2.38M−43.1K (−1.8%)
Value$10.4M$8.00K$3.02M−$7.39M (−71.0%)

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held 9 Meters Biopharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to NMTR in Q4 2022
InstitutionSharesValue% of portfolio
Hudson Bay Capital Management LP25,001$31.5K0.00%
Dimensional Fund Advisors LP16,519$21.0K0.00%
Hartford Financial Management Inc.200$2520.00%
CoreCap Advisors, LLC101$1270.00%
Register Financial Advisors LLC100$1260.00%
TCI Wealth Advisors, Inc.50$630.00%
Cornerstone Planning Group LLC25$520.00%
CWM, LLC6$00.00%

Sold out (38)

Institutions that held 9 Meters Biopharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Not filed for Q4 2022 yet (2)

Institutions that held 9 Meters Biopharma, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NMTR in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Ashfield Capital Partners, LLC33,353$7.00K
Wipfli Financial Advisors LLC,4,500$1.00K